U.S. Court of Appeals for the Federal Circuit, 2011

Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.

Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.
U.S. Court of Appeals for the Federal Circuit · Decided July 21, 2011
426 F. App'x 904

Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.

Opinion of the Court

ORDER

Upon consideration of the order of the Supreme Court of the United States in Eisai Co., Ltd., et al. v. Teva Phamaceuticals USA, Inc. Through its Gate Pharmaceuticals Division, — U.S. -, 131 S.Ct. 2991, 180 L.Ed.2d 818 (2011), vacating this court’s judgment,

It is Ordered That:

(1) The mandate of this court issued on December 13, 2010 is recalled, the appeal is reinstated, and this court’s October 6, 2010 judgment is vacated.

(2) The appeal is remanded to the district court with instructions to dismiss the complaint as moot.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.